Compare CGEN & PCYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CGEN | PCYO |
|---|---|---|
| Founded | 1993 | 1976 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Water Supply |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 270.4M | 242.8M |
| IPO Year | 2001 | 1995 |
| Metric | CGEN | PCYO |
|---|---|---|
| Price | $2.85 | $11.17 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $5.00 | N/A |
| AVG Volume (30 Days) | ★ 518.7K | 35.3K |
| Earning Date | 05-18-2026 | 04-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 12.50 |
| EPS | N/A | ★ 0.23 |
| Revenue | N/A | ★ $1,227,787.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $75.09 | N/A |
| P/E Ratio | ★ N/A | $48.67 |
| Revenue Growth | N/A | ★ 171.54 |
| 52 Week Low | $1.29 | $9.65 |
| 52 Week High | $3.24 | $12.44 |
| Indicator | CGEN | PCYO |
|---|---|---|
| Relative Strength Index (RSI) | 57.92 | 47.39 |
| Support Level | $1.46 | $10.71 |
| Resistance Level | $3.24 | $11.43 |
| Average True Range (ATR) | 0.16 | 0.41 |
| MACD | -0.02 | -0.06 |
| Stochastic Oscillator | 44.60 | 15.33 |
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs: COM701, COM902, rilvegostomig, and GS-0321 (previously COM503), targeting immune checkpoints the company discovered computationally. The company's revenues are generated mainly from collaborative and license agreements. Geographically, it generates maximum revenue from the United Kingdom, and the rest from the United States.
Pure Cycle Corp is a diversified land and water resource development company. The company designs, constructs, manages, operates, and maintains water and wastewater systems. The firm operates in three business segments namely Water and wastewater resource development, Land development, and the Single-Family Rental Segment. It generates maximum revenue from the Land development segment. The land resource development segment includes all the activities necessary to develop and sell finished lots.